Skip to main content
Erschienen in: Cancer Causes & Control 10/2015

01.10.2015 | Original paper

The metabolic syndrome and mammographic breast density in a racially diverse and predominantly immigrant sample of women

verfasst von: Parisa Tehranifar, Angeline Protacio, Karen M. Schmitt, Elise Desperito, Sabine Oskar, Alan J. Potter, Natalie J. Engmann, Mary Beth Terry

Erschienen in: Cancer Causes & Control | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The metabolic syndrome [MetS, clustering of elevated blood pressure, triglycerides and glucose, reduced high-density lipoprotein cholesterol (HDL-C), abdominal obesity] has been associated with increased breast cancer risk, but less is known about its association with mammographic breast density, a strong risk factor for breast cancer.

Methods

We collected data on risk factors, body size, and blood pressure via in-person interviews and examinations and measured glucose, triglycerides, and HDL-C from dried blood spots from women recruited through a mammography screening clinic (n = 373; 68 % Hispanic, 17 % African-American, 63 % foreign born). We performed linear regression models to examine the associations of each MetS component and the MetS cluster (≥3 components) with percent density and dense breast area, measured using a computer-assisted technique and Cumulus software.

Results

About 45 % of women had the MetS, with the prevalence of the individual components ranging from 68 % for abdominal obesity to 33 % for elevated triglycerides. The prevalence of the MetS increased with higher body mass index (BMI) and postmenopausal status, but did not vary substantially by ethnicity, immigrant generational status, parity, age at menarche, or alcohol consumption. Low HDL-C (<50 mg/dL), but not the MetS cluster or the other MetS components, was associated with larger dense breast area after adjusting for age, BMI, fasting time, and educational attainment (β = 8.77, 95 % CI 2.39, 15.14). The MetS and its individual components were not associated with BMI-adjusted percent density.

Conclusions

HDL-C alone may have an influence on dense breast tissue that is independent of BMI, and may be in the same direction as its association with breast cancer risk.
Literatur
1.
Zurück zum Zitat Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17):2735–2752. doi:10.1161/CIRCULATIONAHA.105.169404 CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17):2735–2752. doi:10.​1161/​CIRCULATIONAHA.​105.​169404 CrossRefPubMed
2.
Zurück zum Zitat Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644 CrossRefPubMed Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645. doi:10.​1161/​CIRCULATIONAHA.​109.​192644 CrossRefPubMed
7.
9.
Zurück zum Zitat Bjorge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J et al (2010) Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomark Prev 19(7):1737–1745. doi:10.1158/1055-9965.EPI-10-0230 CrossRef Bjorge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J et al (2010) Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomark Prev 19(7):1737–1745. doi:10.​1158/​1055-9965.​EPI-10-0230 CrossRef
10.
Zurück zum Zitat Oza AM, Boyd NF (1993) Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev 15(1):196–208PubMed Oza AM, Boyd NF (1993) Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev 15(1):196–208PubMed
11.
Zurück zum Zitat Yaghjyan L, Colditz GA, Rosner B, Tamimi RM (2013) Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to the time since the mammogram. Cancer Epidemiol Biomark Prev 22(6):1110–1117. doi:10.1158/1055-9965.EPI-13-0169 CrossRef Yaghjyan L, Colditz GA, Rosner B, Tamimi RM (2013) Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to the time since the mammogram. Cancer Epidemiol Biomark Prev 22(6):1110–1117. doi:10.​1158/​1055-9965.​EPI-13-0169 CrossRef
13.
Zurück zum Zitat Pettersson A, Graff RE, Ursin G, Santos Silva ID, McCormack V, Baglietto L et al (2014) Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. doi:10.1093/jnci/dju078 PubMed Pettersson A, Graff RE, Ursin G, Santos Silva ID, McCormack V, Baglietto L et al (2014) Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. doi:10.​1093/​jnci/​dju078 PubMed
16.
Zurück zum Zitat Roubidoux MA, Kaur JS, Griffith KA, Sloan J, Wilson C, Novotny P et al (2003) Correlates of mammogram density in southwestern Native-American women. Cancer Epidemiol Biomark Prev 12(6):552–558 Roubidoux MA, Kaur JS, Griffith KA, Sloan J, Wilson C, Novotny P et al (2003) Correlates of mammogram density in southwestern Native-American women. Cancer Epidemiol Biomark Prev 12(6):552–558
17.
Zurück zum Zitat Sellers TA, Jensen LE, Vierkant RA, Fredericksen ZS, Brandt KR, Giuliano AR et al (2007) Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study. Cancer Cause Control 18(5):505–515. doi:10.1007/s10552-007-0128-9 CrossRef Sellers TA, Jensen LE, Vierkant RA, Fredericksen ZS, Brandt KR, Giuliano AR et al (2007) Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study. Cancer Cause Control 18(5):505–515. doi:10.​1007/​s10552-007-0128-9 CrossRef
18.
Zurück zum Zitat Boyd NF, Lockwood GA, Byng JW, Little LE, Yaffe MJ, Tritchler DL (1998) The relationship of anthropometric measures to radiological features of the breast in premenopausal women. Br J Cancer 78(9):1233–1238CrossRefPubMedCentralPubMed Boyd NF, Lockwood GA, Byng JW, Little LE, Yaffe MJ, Tritchler DL (1998) The relationship of anthropometric measures to radiological features of the breast in premenopausal women. Br J Cancer 78(9):1233–1238CrossRefPubMedCentralPubMed
19.
Zurück zum Zitat Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G et al (2006) Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomark Prev 15(11):2086–2092CrossRef Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G et al (2006) Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomark Prev 15(11):2086–2092CrossRef
20.
Zurück zum Zitat Reeves KW, Stone RA, Modugno F, Ness RB, Vogel VG, Weissfeld JL et al (2009) Longitudinal association of anthropometry with mammographic breast density in the study of women’s health across the nation. Int J Cancer 124(5):1169–1177CrossRefPubMedCentralPubMed Reeves KW, Stone RA, Modugno F, Ness RB, Vogel VG, Weissfeld JL et al (2009) Longitudinal association of anthropometry with mammographic breast density in the study of women’s health across the nation. Int J Cancer 124(5):1169–1177CrossRefPubMedCentralPubMed
24.
25.
Zurück zum Zitat Boyd NF, Connelly P, Byng J, Yaffe M, Draper H, Little L et al (1995) Plasma lipids, lipoproteins and mammographic densities. Cancer Epidemiol Biomark Prev 4(7):727–733 Boyd NF, Connelly P, Byng J, Yaffe M, Draper H, Little L et al (1995) Plasma lipids, lipoproteins and mammographic densities. Cancer Epidemiol Biomark Prev 4(7):727–733
26.
Zurück zum Zitat Maskarinec G, Lyu LC, Meng L, Theriault A, Ursin G (2001) Determinants of mammographic densities among women of Asian, Native Hawaiian and Caucasian ancestry. Ethn Dis 11(1):44–50PubMed Maskarinec G, Lyu LC, Meng L, Theriault A, Ursin G (2001) Determinants of mammographic densities among women of Asian, Native Hawaiian and Caucasian ancestry. Ethn Dis 11(1):44–50PubMed
27.
Zurück zum Zitat Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter J, Ulrich CM et al (2005) Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomark Prev 14(6):1411–1417. doi:10.1158/1055-9965.EPI-04-0920 CrossRef Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter J, Ulrich CM et al (2005) Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomark Prev 14(6):1411–1417. doi:10.​1158/​1055-9965.​EPI-04-0920 CrossRef
30.
Zurück zum Zitat Keegan TH, John EM, Fish KM, Alfaro-Velcamp T, Clarke CA, Gomez SL (2010) Breast cancer incidence patterns among California Hispanic women: differences by nativity and residence in an enclave. Cancer Epidemiol Biomark Prev 19(5):1208–1218. doi:10.1158/1055-9965.EPI-10-0021 CrossRef Keegan TH, John EM, Fish KM, Alfaro-Velcamp T, Clarke CA, Gomez SL (2010) Breast cancer incidence patterns among California Hispanic women: differences by nativity and residence in an enclave. Cancer Epidemiol Biomark Prev 19(5):1208–1218. doi:10.​1158/​1055-9965.​EPI-10-0021 CrossRef
32.
Zurück zum Zitat Habel LA, Capra AM, Oestreicher N, Greendale GA, Cauley JA, Bromberger J et al (2007) Mammographic density in a multiethnic cohort. Menopause 14(5):891–899CrossRefPubMed Habel LA, Capra AM, Oestreicher N, Greendale GA, Cauley JA, Bromberger J et al (2007) Mammographic density in a multiethnic cohort. Menopause 14(5):891–899CrossRefPubMed
33.
Zurück zum Zitat Tseng M, Byrne C, Evers KA, London WT, Daly MB (2006) Acculturation and breast density in foreign-born, U.S. Chinese women. Cancer Epidemiol Biomark Prev 15(7):1301–1305CrossRef Tseng M, Byrne C, Evers KA, London WT, Daly MB (2006) Acculturation and breast density in foreign-born, U.S. Chinese women. Cancer Epidemiol Biomark Prev 15(7):1301–1305CrossRef
34.
Zurück zum Zitat Maskarinec G, Pagano I, Chen Z, Nagata C, Gram IT (2007) Ethnic and geographic differences in mammographic density and their association with breast cancer incidence. Breast Cancer Res Treat 104(1):47–56. doi:10.1007/s10549-006-9387-5 CrossRefPubMed Maskarinec G, Pagano I, Chen Z, Nagata C, Gram IT (2007) Ethnic and geographic differences in mammographic density and their association with breast cancer incidence. Breast Cancer Res Treat 104(1):47–56. doi:10.​1007/​s10549-006-9387-5 CrossRefPubMed
35.
36.
Zurück zum Zitat Rodriguez F, Naderi S, Wang Y, Johnson CE, Foody JM (2013) High prevalence of metabolic syndrome in young Hispanic women: findings from the national sister to sister campaign. Metab Syndr Relat disord 11(2):81–86. doi:10.1089/met.2012.0109 CrossRefPubMed Rodriguez F, Naderi S, Wang Y, Johnson CE, Foody JM (2013) High prevalence of metabolic syndrome in young Hispanic women: findings from the national sister to sister campaign. Metab Syndr Relat disord 11(2):81–86. doi:10.​1089/​met.​2012.​0109 CrossRefPubMed
38.
Zurück zum Zitat Abraido-Lanza AF, Martins MC, Shelton RC, Florez KR (2015) Breast cancer screening among Dominican Latinas: a closer look at fatalism and other social and cultural factors. Health Educ Behav. doi:10.1177/1090198115580975 Abraido-Lanza AF, Martins MC, Shelton RC, Florez KR (2015) Breast cancer screening among Dominican Latinas: a closer look at fatalism and other social and cultural factors. Health Educ Behav. doi:10.​1177/​1090198115580975​
39.
Zurück zum Zitat Third Report of the National Cholesterol Education Program (NCEP) (2002) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106(25):3143–3421 Third Report of the National Cholesterol Education Program (NCEP) (2002) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106(25):3143–3421
40.
Zurück zum Zitat Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994) The quantitative analysis of mammographic densities. Phys Med Biol 39(10):1629–1638CrossRefPubMed Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994) The quantitative analysis of mammographic densities. Phys Med Biol 39(10):1629–1638CrossRefPubMed
41.
Zurück zum Zitat Borugian MJ, Spinelli JJ, Gordon PB, Abanto Z, Brooks-Wilson A, Pollak MN et al (2014) Fasting insulin and endogenous hormones in relation to premenopausal breast density (Canada). Cancer Cause Control 25(3):385–394. doi:10.1007/s10552-014-0339-9 CrossRef Borugian MJ, Spinelli JJ, Gordon PB, Abanto Z, Brooks-Wilson A, Pollak MN et al (2014) Fasting insulin and endogenous hormones in relation to premenopausal breast density (Canada). Cancer Cause Control 25(3):385–394. doi:10.​1007/​s10552-014-0339-9 CrossRef
42.
Zurück zum Zitat Woolcott CG, Courneya KS, Boyd NF, Yaffe MJ, McTiernan A, Brant R et al (2013) Association between sex hormones, glucose homeostasis, adipokines, and inflammatory markers and mammographic density among postmenopausal women. Breast Cancer Res Treat 139(1):255–265. doi:10.1007/s10549-013-2534-x CrossRefPubMed Woolcott CG, Courneya KS, Boyd NF, Yaffe MJ, McTiernan A, Brant R et al (2013) Association between sex hormones, glucose homeostasis, adipokines, and inflammatory markers and mammographic density among postmenopausal women. Breast Cancer Res Treat 139(1):255–265. doi:10.​1007/​s10549-013-2534-x CrossRefPubMed
43.
Zurück zum Zitat Furberg AS, Jasienska G, Bjurstam N, Torjesen PA, Emaus A, Lipson SF et al (2005) Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA study. Cancer Epidemiol Biomark Prev 14(1):33–40 Furberg AS, Jasienska G, Bjurstam N, Torjesen PA, Emaus A, Lipson SF et al (2005) Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA study. Cancer Epidemiol Biomark Prev 14(1):33–40
44.
Zurück zum Zitat Flote VG, Frydenberg H, Ursin G, Iversen A, Fagerland MW, Ellison PT et al (2015) High-density lipoprotein-cholesterol, daily estradiol and progesterone, and mammographic density phenotypes in premenopausal women. Cancer prev Res 8(6):535–544. doi:10.1158/1940-6207.CAPR-14-0267 CrossRef Flote VG, Frydenberg H, Ursin G, Iversen A, Fagerland MW, Ellison PT et al (2015) High-density lipoprotein-cholesterol, daily estradiol and progesterone, and mammographic density phenotypes in premenopausal women. Cancer prev Res 8(6):535–544. doi:10.​1158/​1940-6207.​CAPR-14-0267 CrossRef
45.
Zurück zum Zitat Ferraroni M, Gerber M, Decarli A, Richardson S, Marubini E, Crastes de Paulet P et al (1993) HDL-cholesterol and breast cancer: a joint study in northern Italy and southern France. Int J Epidemiol 22(5):772–780CrossRefPubMed Ferraroni M, Gerber M, Decarli A, Richardson S, Marubini E, Crastes de Paulet P et al (1993) HDL-cholesterol and breast cancer: a joint study in northern Italy and southern France. Int J Epidemiol 22(5):772–780CrossRefPubMed
46.
Zurück zum Zitat Gaard M, Tretli S, Urdal P (1994) Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women. Cancer Causes Control 5(6):501–509CrossRefPubMed Gaard M, Tretli S, Urdal P (1994) Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women. Cancer Causes Control 5(6):501–509CrossRefPubMed
47.
Zurück zum Zitat Martin LJ, Melnichouk O, Huszti E, Connelly PW, Greenberg CV, Minkin S et al (2015) Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points. J Natl Cancer Inst 107(5). doi:10.1093/jnci/djv032 Martin LJ, Melnichouk O, Huszti E, Connelly PW, Greenberg CV, Minkin S et al (2015) Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points. J Natl Cancer Inst 107(5). doi:10.​1093/​jnci/​djv032
48.
Zurück zum Zitat Llanos AA, Makambi KH, Tucker CA, Wallington SF, Shields PG, Adams-Campbell LL (2012) Cholesterol, lipoproteins, and breast cancer risk in African American women. Ethn Dis 22(3):281–287PubMedCentralPubMed Llanos AA, Makambi KH, Tucker CA, Wallington SF, Shields PG, Adams-Campbell LL (2012) Cholesterol, lipoproteins, and breast cancer risk in African American women. Ethn Dis 22(3):281–287PubMedCentralPubMed
49.
Zurück zum Zitat Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96(15):1152–1160. doi:10.1093/jnci/djh216 CrossRefPubMed Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96(15):1152–1160. doi:10.​1093/​jnci/​djh216 CrossRefPubMed
50.
Zurück zum Zitat Kim Y, Park SK, Han W, Kim DH, Hong YC, Ha EH et al (2009) Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea. Cancer Epidemiol Biomark Prev 18(2):508–515. doi:10.1158/1055-9965.EPI-08-0133 CrossRef Kim Y, Park SK, Han W, Kim DH, Hong YC, Ha EH et al (2009) Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea. Cancer Epidemiol Biomark Prev 18(2):508–515. doi:10.​1158/​1055-9965.​EPI-08-0133 CrossRef
51.
Zurück zum Zitat Moorman PG, Hulka BS, Hiatt RA, Krieger N, Newman B, Vogelman JH et al (1998) Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomark Prev 7(6):483–488 Moorman PG, Hulka BS, Hiatt RA, Krieger N, Newman B, Vogelman JH et al (1998) Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomark Prev 7(6):483–488
54.
Zurück zum Zitat Lakshmy R, Gupta R, Prabhakaran D, Snehi U, Reddy KS (2010) Utility of dried blood spots for measurement of cholesterol and triglycerides in a surveillance study. J Diabetes Sci Technol 4(2):258–262CrossRefPubMedCentralPubMed Lakshmy R, Gupta R, Prabhakaran D, Snehi U, Reddy KS (2010) Utility of dried blood spots for measurement of cholesterol and triglycerides in a surveillance study. J Diabetes Sci Technol 4(2):258–262CrossRefPubMedCentralPubMed
55.
Zurück zum Zitat Lakshmy R, Mathur P, Gupta R, Shah B, Anand K, Mohan V et al (2012) Measurement of cholesterol and triglycerides from a dried blood spot in an Indian Council of Medical Research-World Health Organization multicentric survey on risk factors for noncommunicable diseases in India. J Clin Lipidol 6(1):33–41. doi:10.1016/j.jacl.2011.10.021 CrossRefPubMed Lakshmy R, Mathur P, Gupta R, Shah B, Anand K, Mohan V et al (2012) Measurement of cholesterol and triglycerides from a dried blood spot in an Indian Council of Medical Research-World Health Organization multicentric survey on risk factors for noncommunicable diseases in India. J Clin Lipidol 6(1):33–41. doi:10.​1016/​j.​jacl.​2011.​10.​021 CrossRefPubMed
57.
Zurück zum Zitat Abyholm AS (1981) Determination of glucose in dried filter paper blood spots. Scand J Clin Lab Investig 41(3):269–274CrossRef Abyholm AS (1981) Determination of glucose in dried filter paper blood spots. Scand J Clin Lab Investig 41(3):269–274CrossRef
58.
Zurück zum Zitat Winocour PH, McKinnon GA, McMurray JR, Anderson DC (1985) Evaluation of the measurement of blood glucose levels on dried filter paper blood spots. Diabet Med 2(4):269–271PubMed Winocour PH, McKinnon GA, McMurray JR, Anderson DC (1985) Evaluation of the measurement of blood glucose levels on dried filter paper blood spots. Diabet Med 2(4):269–271PubMed
59.
Zurück zum Zitat McDade TW, Williams S, Snodgrass JJ (2007) What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 44(4):899–925CrossRefPubMed McDade TW, Williams S, Snodgrass JJ (2007) What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 44(4):899–925CrossRefPubMed
Metadaten
Titel
The metabolic syndrome and mammographic breast density in a racially diverse and predominantly immigrant sample of women
verfasst von
Parisa Tehranifar
Angeline Protacio
Karen M. Schmitt
Elise Desperito
Sabine Oskar
Alan J. Potter
Natalie J. Engmann
Mary Beth Terry
Publikationsdatum
01.10.2015
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 10/2015
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-015-0630-4

Weitere Artikel der Ausgabe 10/2015

Cancer Causes & Control 10/2015 Zur Ausgabe

Letter to the Editor

Response to Fornalski et al.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.